Published: 2022-02-28

A comparative study on the fasting and postprandial lipid abnormalities in type 2 diabetes mellitus in tertiary care teaching hospital of southern Rajasthan, India

Sharique Nadeem, Lakhan Singh, Uma Shankar Shukla, Mayank Jain, Vinod Kumar


Background: The worldwide prevalence of diabetes mellitus has risen dramatically. Based on current trends, the International Diabetes Federation projects that 438 million individuals will have diabetes by the year 2030.Type 2 diabetes is characterized by insulin resistance which is associated with hypertension, dyslipidemia, micro and macro vascular disease.

Methods: This study was institutional based Case Control comparative study carried out on 200 type 2 diabetes patients and on 200 healthy controls   at tertiary care teaching hospital in Jhalawar, Rajasthan.  Non-probability purposive sampling technique was used followed by interview of 400 participants.

Results: In final analysis, Diabetes subjects were middle aged (mean age 43.2±7.48 years) with a mean BMI of 26.9±5.46 kg/m2, matched with controls. Among diabetes patients 152 has positive family history for diabetes. The fasting and postprandial lipid profile were increased in the type 2 DM subjects as compared to controls and among the type 2 DM patients, the postprandial lipid parameters were increased as compared to the fasting level.

Conclusions: Both fasting and post prandial lipid abnormalities seen in type 2 diabetes but the post- prandial lipid profile was altered when compare to fasting lipid levels. Lifestyle modifications along with diet and proper lipid lowering drugs are helpful in diabetic individuals with lipid abnormalities.


Abnormalities, Diabetes mellitus, Fasting, Lipid, Postprandial, Type-2

Full Text:



Longo DL. Harrison’s Principles of Internal Medicine. 18th edition. 2012:628,2995-2998.

Bijani PK, Kokila S, Reheja BS. HDL Cholesterol in Diabetes. JAPI. 1984;7:32.

Alvin CP. Screening for Type 2 Diabetes in: Diabetic care. ADA. 2004;27(1):11-4.

Harold EL. Type 2 diabetes mellitus: an overview. Clinical Chemistry. 1999;45(8):1339-45.

Maeda E, Yoshino G, Kasuga M. Diabetes mellitus as a risk factor for arteriosclerosis. Nippon Rinsho. 1993;51(8):2170-6.

Tushuizen MF, Diamant M, Heine RJ. Postprandial dysmetabolism and cardiovascular disease in Type 2 Diabetes. Postgrad Med J. 2005;81:1-6.

Tentolouris N, Stylianou A, Lourida E, Perrea D, et al. High postprandial triglyceridemia in patients with Type 2 Diabetes and microalbuminuria. J Lipid Research. 2007;48:218-25.

Axelsen M, Smith U, Eriksson JW, Jansson PA. Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with Type 2 Diabetes. Ann Intern Med. 1999;131:27-31.

Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27(6):1496-504.

Madhu SV, Mittal V, Ram BK, Srivastava DK. Postprandial lipid abnormalities in Type 2 diabetes Mellitus. J Associate Professors India. 2005;53:1043-6.

Vasilios GA, Konstantinos T, Asterios K, Dimitri PM. Dyslipidaemia of obesity, metabolic syndrome and type 2 Diabetes Mellitus: the case for residual risk reduction after statin treatment. Open Cardiovascular Med J. 2011;5:24-34.

Amrane N, Boumediene KM. Effect of overweight and obesity on postprandial lipemia among the subjects with Type 2 Diabetes. J Diabetes Metab. 2012;3(2):1-5.